Earnings Recaps

Browse reported earnings of the most popular stocks

May 16, 2026 May 15, 2026 May 14, 2026 May 13, 2026 May 12, 2026 May 11, 2026 May 10, 2026 May 9, 2026 May 8, 2026 May 7, 2026 May 6, 2026 May 5, 2026 May 4, 2026 May 3, 2026 May 2, 2026 May 1, 2026 Apr 30, 2026 Apr 29, 2026 Apr 23, 2026 Apr 22, 2026 Apr 21, 2026 Apr 20, 2026 Apr 18, 2026 Apr 17, 2026 Apr 16, 2026 Apr 15, 2026 Apr 14, 2026 Apr 13, 2026 Apr 10, 2026 Apr 9, 2026 Apr 8, 2026 Apr 7, 2026 Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026 Jan 7, 2026 Jan 6, 2026 Dec 19, 2025 Dec 18, 2025 Dec 17, 2025 Dec 12, 2025 Dec 11, 2025 Dec 10, 2025 Dec 9, 2025 Dec 6, 2025 Dec 5, 2025 Dec 4, 2025 Dec 3, 2025 Dec 2, 2025 Dec 1, 2025 Nov 27, 2025 Nov 26, 2025 Nov 25, 2025 Nov 24, 2025 Nov 23, 2025 Nov 21, 2025 Nov 20, 2025 Nov 19, 2025 Nov 18, 2025 Nov 17, 2025 Nov 15, 2025 Nov 14, 2025 Nov 13, 2025 Nov 12, 2025 Nov 11, 2025 Nov 10, 2025 Nov 9, 2025 Nov 8, 2025 Nov 7, 2025 Nov 6, 2025 Nov 5, 2025 Nov 4, 2025 Nov 1, 2025 Oct 31, 2025 Oct 30, 2025 Oct 29, 2025 Oct 28, 2025 Oct 27, 2025 Oct 25, 2025 Oct 24, 2025 Oct 23, 2025 Oct 22, 2025 Oct 21, 2025 Oct 17, 2025 Oct 16, 2025 Oct 15, 2025 Oct 14, 2025 Oct 9, 2025 Oct 8, 2025 Oct 7, 2025 Sep 25, 2025 Sep 23, 2025 Sep 17, 2025 Sep 16, 2025 Sep 11, 2025 Sep 10, 2025 Sep 9, 2025 Sep 5, 2025 Sep 4, 2025 Sep 3, 2025
72 companies Today

AbbVie Inc.

ABBV Q1 2026
Reported: 2026-04-30

Shares rose 6.9% following AbbVie’s first quarter, as revenues, EPS, and commercial performance in key franchises decisively beat expectations. Management announced an upward revision to full-year EPS guidance and highlighted strong execution across immunology and neuroscience portfolios. The positive market reaction suggests investors were focused on upside in top and bottom line performance, robust commercial momentum, and the confident guidance raise.

Key takeaways
  • Adjusted EPS for Q1 reached $2.65, $0.07 higher than the mid-point of previous guidance; full-year adjusted EPS guidance was raised by $0.12.
  • Total net revenues came in at $15 billion, exceeding internal expectations by $300 million and representing 12.4% sales growth.
  • Skyrizi sales jumped 29.2% operationally to $4.5 billion, with leadership in key dermatology and IBD indications, while Rinvoq sales rose 20.2% to $2.1 billion.
  • Neuroscience revenues grew 24.3% operationally to nearly $2.9 billion, surpassing internal forecasts.
  • Strategic investments were cited, including $1.4 billion for a new manufacturing campus in North Carolina and ongoing R&D pipeline advances across immunology, obesity, and oncology.

Automatic Data Processing, Inc.

ADP Q3 2026
Reported: 2026-04-30

Shares rose 6.4% following ADP’s Q3 print, as revenue growth, margin expansion, and EPS all came in ahead of expectations. The market responded positively to outperformance across key metrics and constructive commentary on AI-driven product innovation.

Key takeaways
  • Employer Services new business bookings posted solid growth, with international and compliance solutions performing especially well.
  • Insurance and retirement services continued to drive gains within the small business portfolio.
  • Retention rate and overall client satisfaction both reached new record highs for a third quarter.
  • Management highlighted significant adoption and tangible time savings from new AI-driven products, including ADP Assist agents and Lyric HCM.
  • Strategic expansion of the AI ecosystem, including broader third-party integrations via the ADP Marketplace, was called out as a recent milestone.

Align Technology, Inc.

ALGN Q1 2026
Reported: 2026-04-30

Align shares closed down 0.7% post-earnings, indicating a fairly muted investor reaction despite management highlighting year-over-year growth in key segments. Solid Clear Aligner volumes and international growth were balanced by a sequential decline in Systems & Services and overall margin commentary that did not notably exceed expectations.

Key takeaways
  • Q1 revenue was $1.04 billion, up 6.2% year-over-year, primarily driven by Clear Aligner volumes and higher ASPs.
  • Clear Aligner shipments reached a quarterly record of 686,000 cases, up 6.7% year-over-year, and Clear Aligner revenue grew 7.4% to $856 million.
  • All major regions saw double-digit Clear Aligner volume growth except North America, which remained stable.
  • Systems and Services revenue totaled $184 million, up 1% year-over-year but declined sequentially, reflecting anticipated capital equipment seasonality and a continued mix shift toward lower-priced scanner offerings.
  • Doctor utilization and the number of submitting doctors both increased globally, though topline and segment trends appeared largely in line with expectations, as reflected by the modest market move.

Community

See what investors are trading, holding, and sharing

🌐
All
📈
Stock
📊
ETF
🏦
Mutual Fund
🪙
Crypto
💱
Forex
# Asset Price Community % Type Currency Sector
Loading...